BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dos Santos EUD, da Silva IIFG, Asano AGC, Asano NMJ, De Mascena Diniz Maia M, de Souza PRE. Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study. Mol Biol Rep 2020;47:8997-9004. [PMID: 33151475 DOI: 10.1007/s11033-020-05956-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Dwivedi A, Dwivedi N, Kumar A, Singh VK, Pathak A, Chaurasia RN, Mishra VN, Mohanty S, Joshi D. Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson’s Disease: A Meta-Analysis and Systematic Review. J Geriatr Psychiatry Neurol. [DOI: 10.1177/08919887221103580] [Reference Citation Analysis]
2 Fatima TS, Fathima ST, Kandadai RM, Borgohain R, Sreenu B, Kutala VK. Association of Catechol-O-Methyltransferase Gene Polymorphisms and Haplotypes in the Levodopa-Induced Adverse Events in Subjects with Parkinson’s Disease. Ind J Clin Biochem. [DOI: 10.1007/s12291-022-01046-8] [Reference Citation Analysis]
3 Srivastava K, Ochuba O, Sandhu JK, Alkayyali T, Ruo SW, Waqar A, Jain A, Joseph C, Poudel S. Effect of Catechol-O-Methyltransferase Genotype Polymorphism on Neurological and Psychiatric Disorders: Progressing Towards Personalized Medicine. Cureus 2021;13:e18311. [PMID: 34725583 DOI: 10.7759/cureus.18311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yin Y, Liu Y, Xu M, Zhang X, Li C. Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson's disease-a meta-analysis. Neurol Sci 2021;42:4085-94. [PMID: 34346015 DOI: 10.1007/s10072-021-05509-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]